16 results about "Pantothenic acid" patented technology

The present invention provides a novel process for producing panthenol from pantothenic acid or salts and / or esters thereof. The process makes a “hybrid process” possible to produce panthenol, which is generally more eco-friendly and sustainable and reduces carbon print compared to a pure chemical process.

A composition for improving cognitive performance, enhancing mental clarity, increasing focus, and increasing physical and mental energy is disclosed. The composition includes sufficient amounts of Fermented Green Tea Extract, L Theanine, and Caffeine, Ashwagandha Extract, Black Pepper Extract, Huperzine, Fermented Alpha GPC / Citoline Matrix, Turmeric Root Extract, Lions Mane Extract, Ginkgo Biloba Powder Extract, Panax Ginseng Extract, Rhodiola Extract, Cognitive Probiotic Blend, Folic Acid, Vitamin D3, Vitamin C Powder, Vitamin B12, Vitamin B6, Pantothenic Acid, Vitamin B3 Crystalline Powder, Vitamin B2 Powder, Vitamin B1 HCL, and Biotin.

The present disclosure provides compositions and methods for providing a health benefit to a growing animal comprising administering a food composition to the animal, wherein the food composition includes a brain development blend. The brain development blend generally comprises DHA, EPA, taurine, choline, thiamine, riboflavin, pantothenic acid, niacin, pyridoxine, vitamin B12, and folic acid.

This invention discloses a primer and probe composition for the quantitative detection of the pathogen causing leaf spot disease in wild apricot and its application, belonging to the field of agricultural biotechnology. The primer and probe composition for the quantitative detection of the pathogen causing leaf spot disease in wild apricot is mentioned, wherein the pathogen is *Scutellaria cirrhosa* (*Scutellaria cirrhosa*). Wilsonomyces carpophilus ) and / or clusters of pantothenic acid ( Pantoea agglomerans The primer-probe composition comprises a first primer pair and a first probe W.car-P for detecting *Cyclophorus frutescens*, and a second primer pair and a second probe P.agg-P for detecting *Pantotheca acuminata*. The purpose of this invention is to provide a primer-probe composition for the quantitative detection of the pathogen causing leaf spot disease in wild apricots and its application. This primer-probe composition exhibits high sensitivity, strong specificity, good stability, and high repeatability, enabling rapid and simultaneous detection of *Cyclophorus frutescens* and *Pantotheca acuminata*.

The application relates to the technical field of microbial culture medium, and discloses a chemical component limited culture medium for supporting growth of bifidobacterium and application thereof. The CDM comprises a carbon source, salts, amino acids, vitamins and water; the carbon source is selected from at least one of glucose, fructose, lactose, maltose and galactooligosaccharide, the salts comprise sodium acetate, potassium hydrogen phosphate, ammonium acetate, magnesium sulfate heptahydrate, ferrous sulfate heptahydrate, sodium chloride and manganese sulfate monohydrate, the amino acids comprise alanine, cystine, cysteine, tryptophan and asparagine, and the vitamins comprise pyridoxine hydrochloride, nicotinic acid, calcium pantothenate, thiamine hydrochloride, riboflavin, p-aminobenzoic acid, folic acid and biotin. The CDM of the application is a liquid culture medium, only comprises 21 definite components, is simple in components, convenient in preparation, and is high in universality, and can effectively support growth of bifidobacterium.

This invention discloses a nine-vitamin cod liver oil, comprising 8-12 parts cod liver oil, 1-1.4 parts vitamin A, 0.02-0.04 parts vitamin D3, 0.8-1.2 parts vitamin B1, 0.7-0.8 parts vitamin B2, 0.4-0.6 parts vitamin B6, 27-33 parts vitamin C, 0.4-0.6 parts vitamin E, 0.2-0.4 parts nicotinamide, 0.4-0.6 parts calcium pantothenate, 70-80 parts polysorbate 80, 0.1-0.6 parts fat-soluble antioxidant, 0.5-4 parts fat-soluble preservative, 8-12 parts water-soluble preservative, 4-6 parts water-soluble antioxidant, 40-50 parts sodium bicarbonate, 22-30 parts citric acid, 44-60 parts sodium citrate, and 3200-4800 parts sucrose. This invention provides a nine-dimensional cod liver oil and its preparation method, which can not only maintain the clarity of the liquid, but also keep the content of indicator components stable.

A composition for improving female health, sexual performance, and benefiting the gut-brain axis is disclosed. The composition includes sufficient amounts of Black Cohosh Extract 20:1, Black Pepper Pepper Extract (95% piperine), Korean Red Ginseng 8:1, Ginkgo Biloba Leaf 8:1, Horny Goat Weed Extract 8:1, Tribulis Terrestris vine 8:1, Avena Sativa Extract Seed 8:1, Pine Bark Extract 8:1, Muira Pauma Extract 8:1, Lemon Balm P.E. 4:1 (Melissa officinalis folium), Red Raspberry Leaf Extract 4:1, Damiana Leaf Extract 4:1, Butea Superba Root 8:1, Ashwagandha Extract 4:1, L-Arginine HCL Powder, L-Citrulline, a Probiotic Blend, TKA 200, Fermented Green Tea Extract with L-Theanine and Caffeine, Folic Acid, Zinc Aspartate, Vitamin E (D-alpha Tocopheryl Acetate), Vitamin D3, Vitamin C (Ascorbic Acid), Vitamin B12 (Methyl cobalamin), Vitamin B6 (Pyridoxine HCL), Pantothenic Acid (D-Calcium Pantothenate), Vitamin B3 Crystalline Powder (Niacinamide), Vitamin B2 Powder (Riboflavin), Biotin (D-biotin), Vitamin B1 HCl (Thiamine HCL).

The application belongs to the technical field of nutrition, and particularly relates to a special medical composition for pregnant women and a preparation method and application thereof. The composition comprises the following components: DHA in the form of phospholipid, active folic acid, vitamin B1, vitamin B2, vitamin B6, vitamin B1, vitamin A, vitamin D, vitamin C, nicotinic acid, pantothenic acid, calcium element, iron element and zinc element. The calcium element is derived from calcium carbonate, the iron element is derived from ferrous gluconate, and the zinc element is derived from zinc sulfate. The composition provided by the application can act on the key window before pregnancy and in the early pregnancy period, and actively perform nutrition storage and metabolism regulation by using high-bioavailability key nutrients such as DHA in the form of phospholipid and active folic acid, and combining specific proportions of B vitamins, vitamin C, vitamin A, vitamin D and minerals.

The present disclosure provides a method of treating an organic acidemia (e.g., propionic acidemia (PA) and / or methyl-malonic acidemia (MMA)) or Pantothenate Kinase Associated Neurodegeneration (PKAN) in a subject with a therapeutically effective amount of a compound represented by formula (I): a pharmaceutically acceptable salt, hydrate, solvate, or a combination thereof. In particular, the subject has propionic acidemia (PA) and / or methylmalonic acidemia (MMA).

The application belongs to the technical field of biological detection, and particularly relates to a probe compound for CoA detection, a fluorescent probe and application, comprising a modified rhodamine series fluorescent dye, a pantothenate kinase inhibitor, a HaloTag, a Nanoluc luciferase and a pantothenate kinase fusion protein; through protein labeling, a series of biosensors are obtained, coenzyme A concentration in living cells can be rapidly detected, and rapid screening of coenzyme A drugs is regulated; through rational design and modification of the chemical probe molecules, and engineering modification of the sensor proteins, the chemical probes can label the sensor proteins in living cells, and then the bioluminescent sensors working in living cells are obtained, the requirements of rapid and high-sensitivity detection of CoA can be met, and the drugs capable of regulating the change of coenzyme A concentration can be high-throughput screened.

The application discloses a kind of vitamin mineral beverage, wherein the component content of each 1000kg drinking water is: vitamin A 300-400mg, vitamin C 50000-60000mg, vitamin D33.8-5mg, vitamin E 6000-8500mg, vitamin B1600-900mg, vitamin B2600-900mg, vitamin B6900-1500mg, vitamin B120.9-1.5mg, nicotinamide 6000-9000mg, biotin 16000-20500mg, pantothenic acid 2800-4400mg, folic acid 320-440mg, calcium carbonate 336000-560000mg, pyrophosphate iron 4500-6500mg, zinc oxide 4500-7500mg, selenium-rich yeast 16-20mg, copper citrate 4500-7500mg, manganese citrate 2000-4000mg, sweetener 150-200g, essence 200-300g, the application provides the vitamin and mineral substance needed by human body, solve the problem of insufficient vitamin mineral intake, prevent deficiency, improve immunity, achieve the effect of nutrition and health care.

The present application belongs to the technical field of aquaculture, and particularly relates to a Decapterus maruadsi breeding feed and application thereof in improving quality of Decapterus maruadsi fertilized eggs. The present application provides a Decapterus maruadsi breeding feed, which comprises two independent first and second feeds; the first feed comprises a basic feed, fish pulp and a nutritional supplement; the second feed comprises the first feed and oyster meat; and the nutritional supplement comprises calcium pantothenate, vitamin B1, vitamin B2, vitamin B6, vitamin C and vitamin F. The Decapterus maruadsi breeding feed can be used for nutritional supplement of Decapterus maruadsi parent fish, so as to promote synchronous development of gonads of male and female parent fish, improve quality of Decapterus maruadsi fertilized eggs, and increase good egg rate of Decapterus maruadsi fertilized eggs to 88.50%, which is 39.15% higher than that of a control group, and improve fertilization rate of Decapterus maruadsi fertilized eggs to 79.58%, which is 19.46% higher than that of the control group.

Provided herein are perfusate compositions, and methods and systems for using such composition to perfuse a vascularized composite tissue (e.g., limb, face, abdominal wall or flap) to preserve such composite tissues (e.g., for auto or allotransplant). In certain embodiments, the perfusate compositions comprise at least one of the following reagents: i) N-acetylcysteine; ii) pantothenate or pantothenic acid at a concentration of at least 15 micromol / liter in said composition; and / or iii) carnitine, as well as further comprising one of the following: i) at least one bicarbonate / CO2-dependent anaplerotic substrate, and at least one bicarbonate / CO2 buffer, or ii) at least one non-bicarbonate / CO2-dependent anaplerotic substrate. In certain embodiments, the perfusate compositions are free, or detectably free, of alpha amino acids.

The application discloses a multi-effect coupling vacuum continuous desolventizing device and method for preparing D-calcium pantothenate. The device comprises a first-stage flash tank, a feed preheater connected with the first-stage flash tank, a second-stage flash tank connected with a liquid phase discharge port of the first-stage flash tank, and a crystallization rectifier connected with a liquid phase discharge port of the second-stage flash tank. The device further comprises a deamination tower connected with gas phase discharge ports of the first-stage flash tank, the second-stage flash tank and the crystallization rectifier, a vacuum pump connected with a gas phase discharge port of the deamination tower, an absorption tower connected with a discharge port of the vacuum pump, and a refining tower connected with a discharge port of the absorption tower. The device further comprises an atmospheric tower connected with a liquid phase discharge port of the deamination tower and a high-pressure tower connected with a liquid phase discharge port of the atmospheric tower. The application adopts step-by-step flash evaporation, utilizes different relative volatility of solvents under different pressures to realize separation, and simultaneously utilizes the coupling rectification principle to make gas phase of one tower as a heat source of another tower, thereby achieving the purpose of energy saving.

Composition comprising: a) Omega-3 fatty acids up to 1.5 g; b) Bacopa monnieri up to 600 mg; c) Ginkgo biloba up to 240 mg; d) Ginseng up to 2 g; e) Taurine up to 6 g; f) Phosphatidylserine up to 300 mg; g) Pantothenic acid up to 10 g; and h) Vitamin B1 up to 10 mg.

The present invention provides the cosmetic use of L-aspartate or a mixture thereof with L-valine in a cosmetic skin care composition as an active ingredient for increasing the biosynthesis of pantothenate by resident commensal microorganisms on the skin of an individual. The present invention also provides L-aspartate or a mixture thereof with L-valine for use in increasing the biosynthesis of pantothenate by resident commensal microorganisms on the skin of an individual.